Table 7.
Targets for lipid control
| Parameter | Target | Population | Guideline | References | |
|---|---|---|---|---|---|
| Lipid | LDL-C | Reduction of ≥ 50% or more from baseline | Adults with diabetes and 10 year atherosclerotic CVD risk of 20% or higher | ADA | [91] |
| LDL-C | Reduction of ≥ 50% from baseline | Patients with DM and atherosclerotic CVD | AHA | [39] | |
| LDL-C | Reduction of ≥ 50% from baseline and < 70 mg/dL | Patients with T2DM > 40 years of age at high CVD risk | ESC | [41] | |
| LDL-C Reduction of ≥ 50% from baseline and < 55 mg/dL | Patients with T2DM at very high CVD risk | ||||
| LDL-C | < 100 mg/dL | Patients with T2DM at moderate CV risk | ESC/EASD | [94] | |
| < 70 mg/dL | Patients with T2DM at high CV risk | ||||
| < 55 mg/dL | Patients with T2DM at very high CV risk | ||||
CV cardiovascular, ASCVD atherosclerotic cardiovascular disease, ADA American Diabetes Association, ESC European Society of Cardiology, EASD European Association for the Study of Diabetes, AHA American Heart Association, LDL-C low-density lipoprotein cholesterol, HDL-C high-density lipoprotein cholesterol, DM diabetes mellitus